Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
JAMA Oncology
|
October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Kartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.
Nature Communications
|
December 21, 2017
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
David Liu, Philip Abbosh, Daniel Keliher, et al.
Nature Communications
|
November 28, 2025
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial
Adrienne G Waks, Jingxin Fu, Xiangying Chu, et al.
Nature Communications
|
September 22, 2021
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
Tanya E Keenan, Jennifer L Guerriero, Romualdo Barroso-Sousa, et al.
JAMA Oncology
|
January 25, 2019
Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors
Saud H AlDubayan, Louise C Pyle, Marija Gamulin, et al.
Nature Communications
|
June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
Tarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Science Advances
|
November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
Giuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Cancer Discovery
|
March 12, 2021
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
Navin R Mahadevan, Erik H Knelson, Jacquelyn O Wolff, et al.
Cancer Research
|
October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma
Jessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
JAMA Oncology
|
October 24, 2024
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Kartik Sehgal, Theodora Pappa, Kee-Young Shin, et al.
Nature Communications
|
December 21, 2017
Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
David Liu, Philip Abbosh, Daniel Keliher, et al.
Nature Communications
|
November 28, 2025
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial
Adrienne G Waks, Jingxin Fu, Xiangying Chu, et al.
Nature Communications
|
September 22, 2021
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer
Tanya E Keenan, Jennifer L Guerriero, Romualdo Barroso-Sousa, et al.
JAMA Oncology
|
January 25, 2019
Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors
Saud H AlDubayan, Louise C Pyle, Marija Gamulin, et al.
Nature Communications
|
June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant
Tarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.
Journal for Immunotherapy of Cancer
|
January 25, 2024
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Brandon M Huffman, Harshabad Singh, Lestat R Ali, et al.
Science Advances
|
November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
Giuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Cancer Discovery
|
March 12, 2021
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity
Navin R Mahadevan, Erik H Knelson, Jacquelyn O Wolff, et al.
Cancer Research
|
October 13, 2020
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma
Jessica M Rusert, Edwin F Juarez, Sebastian Brabetz, et al.
Page
of 5